Medical drugs
US FDA qualifies first AI tool to help speed liver disease drug development
Drug developers are increasingly adopting artificial intelligence technologies
China curbs drug precursors to North America after US trade deal
The controlled substances include various piperidine derivatives and entire families of related compounds used in making fentanyl
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
[BENGALURU] Pfizer on Friday (Oct 31) filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker’s US$8.5 billion bid ...
The Pfizer-Trump deal: A new chapter in drug pricing or political theatre?
The approach may generate headlines while leaving the structural problems of American pharmaceutical pricing unaddressed
HSA refutes Trump claim linking paracetamol and autism
[SINGAPORE] The Health Sciences Authority (HSA) said there is no conclusive scientific evidence linking paracetamol use during pregnancy to autism in children, refuting recent assertions made by US Pr...
The US president is wrong on Tylenol
Scientists studying any link between the painkiller paracetamol and autism have reached no firm conclusions
China biotech’s stunning advance is changing the world’s drug pipeline
Chinese’s biotech advances, the scale of which is slowly coming into view, risk becoming another realm of superpower rivalry such as artificial intelligence and electric vehicles
WeightWatchers files bankruptcy as GLP-1 drugs reshape market
Prepackaged bankruptcies generally allow companies to exit Chapter 11 quickly and without disruption to their business or unsecured creditors
China asks drugmakers, hospitals to find US import substitutes
The tit-for-tat escalation has seen both sides ratchet up tariffs on each other’s goods to over 100 per cent, threatening to wipe out commerce between the world’s two largest economies
US pharma tariffs would raise US drug costs by US$51 billion annually, report finds
[LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, boosting US prices by as much as 12.9 per cent if passed on, a report commissi...